Drug Trial Radar · NCT00129922
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
Last checked: Nov 20, 2026Latest source record: Mar 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,289
Actual
Start
Nov 1999
Primary completion
Dec 2005
Study completion Dec 2007
Sponsor
- Lead sponsor
- Spanish Breast Cancer Research GroupAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Bristol-Myers Squibb; Pfizer; Hoffmann-La Roche
- First posted
- Aug 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The efficacy of adjuvant chemotherapy is limited in patients with a high risk of recurrence. Also, for axillary positive node patients, optimum chemotherapy regimens are still under discussion. Some previous studies suggest that, in the subset of node-positive patients, treatments based on sequential administration of anthracyclines and taxanes are more efficient. Paclitaxel dose-dense (weekly) administration renders an improved therapeutic index (activity/toxicity). The study is designed to compare 6 courses of FEC scheme (600/90/600), a combination of proven efficacy in node positive breast cancer patients, versus 4 FEC courses followed by 8 weekly paclitaxel administrations (100mg/m2). The study hypothesis is that 5-year disease-free survival in the control arm will be 60%. The investigators expect to increase this by 8% with the experimental treatment. With an alpha error of 0.05, 80% power, and a post-randomization estimated drop-out rate of 10%, 1250 patients are needed, 625 per arm.
Conditions
- Breast Cancer
Interventions
paclitaxelDrug
FluorouracilDrug
EpirubicinDrug
CyclophosphamideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- disease-free survivalTime frame: 5 years
Locations
64 sites in 1 country. Site status is shown where the registry gives one.
Complejo Hospitalario Universitario A Coruña
A Coruña, Spain
Centro Oncológico de Galicia
A Coruña, Spain
Hospital General Universitario de Alicante
Alicante, Spain
Hospital del Mar
Barcelona, Spain
Clínica Oncológica Corachán
Barcelona, Spain
Hospital Clinic i Provincial
Barcelona, Spain
Hospital Universitario Puerta del Mar
Cadiz, Spain
Hospital General Universitario de Ciudad Real
Ciudad Real, Spain
Hospital Provincial de Córdoba
Córdoba, Spain
Hospital General Universitario de Guadalajara
Guadalajara, Spain
Hospital Juan Ramón Jiménez
Huelva, Spain
Complejo Hospitalario de Jaén
Jaén, Spain
Hospital de León
León, Spain
Hospital Universitario Lucus Augusti
Lugo, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Clínico Universitario San Carlos
Madrid, Spain
Hospital Clínico Unviersitario Virgen de la Victoria
Málaga, Spain
Hospital General Universitario Morales Meseguer
Murcia, Spain
Complejo Hospitalario de Ourense
Ourense, Spain
Hospital Rio Carrión
Palencia, Spain
Hospital Unviersitario de Salamanca
Salamanca, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Hospital Virgen de la Salud
Toledo, Spain
Hospital Provincial de Toledo
Toledo, Spain
Hospital Universitario La Fe
Valencia, Spain
Instituto Valenciano de Oncología
Valencia, Spain
Hospital Clínico Universitario de Valencia
Valencia, Spain
Hospital General Universitario de Valencia
Valencia, Spain
Hospital Universitario Arnau de Vilanova de Valencia
Valencia, Spain
Hospital Universitario Dr. Peset
Valencia, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Spain
Hospital Provincial de Zamora
Zamora, Spain
Hospital Clínico Universitario de Zaragoza "Lozano Blesa"
Zaragoza, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain
Hospital de Txagorritxu
Vitoria-Gasteiz, Álava, Spain
Hospital Universitario Virgen de los Lirios
Alcoy, Alicante, Spain
Hospital General Universitario de Elche
Elche, Alicante, Spain
Hospital General Universitario de Elda
Elda, Alicante, Spain
Hospital Municipal de Badalona
Badalona, Barcelona, Spain
Hospital Unviersitario Germans Trias i Pujol
Badalona, Barcelona, Spain
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.